Method of treating impotence due to spinal cord injury
AssigneePfizer Inc.
InventorsMurray Maytom, Ian Osterloh
Life of this patent
Estimating the term…
Abstract
A class of cGMP PDE inhibitors, including sidenafil and pharmaceutically acceptable salts thereof, which can be used to treat sexual dysfunction in male and female animals, especially humans, with a spinal cord injury. The invention can be used to treat sexual dysfunction in male animals that exhibit essentially no residual penile function.
Claims10
(canceled)
A method of treating sexual dysfunction due to trauma and/or nerve damage which accompanies a spinal cord injury in an animal, comprising orally administering to an animal in need of such treatment an effective amount of sildenafil, having the structure:
- and pharmaceutically acceptable salts thereof.
(canceled)
(canceled)
A method of treating sexual dysfunction due to trauma and/or nerve damage which accompanies a spinal cord injury in an animal, comprising orally administering to an animal in need of such treatment an effective amount of sildenafil, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing either entity.
(canceled)
(canceled)
Dependencies are inferred from the claim text.